Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

AUPH Aurinia Pharmaceuticals Inc

8,85

0,15 (1,72%)

27 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Aurinia Pharmaceuticals Charts.

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Aurinia Pharmaceuticals Charts.

News Aurinia Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Montag 25 November 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 25 November 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 25 November 2024 (3 Tage vor) • Edgar (US Regulatory)

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Montag 18 November 2024 (1 Woche vor) • Business Wire

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024
Freitag 15 November 2024 (2 Wochen vor) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Aurinia to Participate in Jefferies London Healthcare Conference
Donnerstag 14 November 2024 (2 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 13 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Mittwoch 13 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth
Donnerstag 7 November 2024 (3 Wochen vor) • Business Wire

Weitere Aurinia Pharmaceuticals Inc News-Artikel

Grayscale Future of Fina...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen